Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2019 | Story Valentino Ndaba | Photo Charl Devenish
Smoothie Bike challenge
The Smoothie Bike Challenge feeds the body, soul and the mind in support of mental health awareness.

Smoothie lovers at the University of the Free State (UFS) pedalled furiously to create their favourite drink. The Smoothie Bike Challenge was recently introduced to the Bloemfontein Campus community by the Division for Organisational Development and Employee Wellness.

Blending bikes and berries

Kovsies staff members were invited to pop a handful of berries and bananas into a blender attached to a specially adapted bike that uses pedal power to turn the ingredients into a refreshing drink. 

Blending physical exercise and healthy eating is one way to ensure holistic health. The division wanted to raise awareness around mental health and the effects that fitness and healthy food have on the mind. 

Wheelie good fun

“The purpose of this initiative was to involve employees in a fun way to use their bodies to make a healthy drink. Individuals of all fitness levels could participate,” said Burneline Kaars, head of the organisational development and employee wellness division.

A precursor to Mental Health Awareness month

Participants provided the energy to make the smoothie and Employee Wellness provided the ingredients but the initiative also created awareness around mental health. This comes weeks before the country officially enters Mental Health Awareness month.

According to the government: “The month of October has been declared Mental Health Awareness month with the objective of not only educating the public about mental health but to reduce the stigma and discrimination that people with mental illness are often subjected to.”

An estimated 400 million people worldwide suffer from mental or neurological disorders or experience psychosocial problems. Initiatives such as the Smoothie Bike Challenge are some of the ways in which the UFS is attempting to ensure that staff members are taken care of and do not become statistics. In the light of these numbers, it is evident that continuous efforts are necessary to tackle the issue.



News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept